Does post-transplant treatment with imatinib mesylate inhibit graft-versus-leukemia?
- PMID: 15674413
- DOI: 10.1038/sj.leu.2403656
Does post-transplant treatment with imatinib mesylate inhibit graft-versus-leukemia?
Comment on
-
Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro.Leukemia. 2004 Aug;18(8):1332-9. doi: 10.1038/sj.leu.2403401. Leukemia. 2004. PMID: 15190258
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources